Portishead1 / iStock
OptimizeRx, an electronic health record (EHR) based point-of-care solution company for healthcare professionals and patients, has appointed James Lang to its board of directors.
Lang brings to OptimizeRx more than 25 years of experience in healthcare data, analytic, and technology enabled business services. Lang presently serves as an executive advisor to Water Street, a strategic private equity firm focused exclusively on building market-leading companies in healthcare. He is also a director of BioVie, a development-stage company pioneering an innovative therapeutic that targets complications due to liver cirrhosis.
Lang previously served as CEO of Decision Resources Group, a leading healthcare research and consulting company providing high-value healthcare industry analysis and insights, where he helped transform the company into an industry leader. Earlier, he was president of Strategic Decisions Group, a premier global strategy consultancy, and he expanded the life sciences practice and later sold it to IMS Health. He is an active private investor and advisor with healthcare companies, including Boston Heart Diagnostics (acquired by Eurofins) and AlphalmpactRx (acquired by IMS Health).
“Jim is an exceptionally talented businessman with an extensive track record of building successful companies,” said William Febbo, OptimizeRx’s CEO. “He is enthusiastic about our position as the leading player delivering patient and physician support directly within the EHR. He shares our vision of providing the next generation of EHR communication solutions that will leverage the broad market reach and exclusivity of our ePrescribing network.”
Lang commented: “I’m excited to join the company at this pivotal time, particularly given the growth OptimizeRx experienced in the fourth quarter and the recent M&A activity in our market. We are looking forward to continued growth in 2017.”
OptimizeRx, Appointment, EHR, James Lang, US